BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nett V, Erhardt N, Wyatt A, Wissenbach U. Human TRPV6-pathies caused by gene mutations. Biochim Biophys Acta Gen Subj 2021;1865:129873. [PMID: 33610740 DOI: 10.1016/j.bbagen.2021.129873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wolske K, Wyatt A, Wissenbach U. Comments on the evolution of TRPV6. Ann Anat 2021;238:151753. [PMID: 33964462 DOI: 10.1016/j.aanat.2021.151753] [Reference Citation Analysis]
2 Wartenberg P, Lux F, Busch K, Fecher-Trost C, Flockerzi V, Krasteva-Christ G, Boehm U, Weissgerber P. A TRPV6 expression atlas for the mouse. Cell Calcium 2021;100:102481. [PMID: 34628109 DOI: 10.1016/j.ceca.2021.102481] [Reference Citation Analysis]
3 Neuberger A, Nadezhdin KD, Sobolevsky AI. Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun 2021;12:6284. [PMID: 34725357 DOI: 10.1038/s41467-021-26608-x] [Reference Citation Analysis]
4 Yelshanskaya MV, Sobolevsky AI. Ligand-Binding Sites in Vanilloid-Subtype TRP Channels. Front Pharmacol 2022;13:900623. [PMID: 35652046 DOI: 10.3389/fphar.2022.900623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]